Abbott Completes Acquisition of Facet Biotech

Abbott Laboratories (Abbott Park, IL) says it has completed the previously announced acquisition of biotechnology company Facet Biotech (Redwood City, CA), for a total transaction value of about $450 million. The acquisition provides Abbott with a promising biologic intended to treat multiple sclerosis and compounds that complement its existing diverse oncology program. “Facet's depth of biologics experience and sophisticated antibody engineering platforms complement Abbott's current R&D programs in oncology, immunology and other therapeutic...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers